Amino acids with anabolic properties

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 1, Issue 3, 1998, Pages 263-272

  De Bandt, Jean Pascal ^a,c   Cynober, Luc A ^b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; DRUG DERIVATIVE; GLUTAMINE; ORNITHINE; ORNITHINE ALPHA-KETOGLUTARATE; ORNITHINE OXOGLUTARATE; PROTEIN;

ANIMAL; HUMAN; IMMUNE SYSTEM; INTESTINE; METABOLISM; NUTRITIONAL SUPPORT; PHYSIOLOGY; REVIEW;

AMINO ACIDS; ANIMALS; ARGININE; GLUTAMINE; HUMANS; IMMUNE SYSTEM; INTESTINES; NUTRITIONAL SUPPORT; ORNITHINE; PROTEINS;

EID: 0032057738     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199805000-00005     Document Type: Article

References (108)

1. Rennie MJ, McLennan PA, Hundal HS, Weryk B, Smith K, Taylor PM, et al. Skeletal muscle glutamine transport, intramuscular glutamine concentration and muscle protein turnover. Metabolism 1989; 38:47-51.
2. Stehle P, Zander J, Merles N, Puchstein C, Albers S, Lawin P, Fürst P. Effects of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1989; i:231-233.
3. Wernerman J, Hammarqvist F, Vinnars E. α-Ketoglutarate and postoperative muscle catabolism. Lancet 1990; 335:701-703.
4. Hankard RS, Haymond MW, Darmaun D. Effect of glutamine on leucine metabolism in humans. Am J Physiol (Endocrinol Metab) 1996; 271:E748-E754.
5. Mortimore GE, Pösö AR, Lardeux BR. Mechanism and control of protein degradation in liver. Diabetes Metab Rev 1989; 5:49-70.
6. Leverve XM, Caro LHP, Romp PJAM, Meijer AJ. Control of proteolysis in perifused rat hepatocytes. FEBS Lett 1987; 219:455-458.
7. Häussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 1996; 313:697-710.
8. Häussinger D, Roth E, Lang F, Gerok W. Cellular hydration state: an important determinant of protein catabolism in health and disease. Lancet 1993; 341:1330-1332.
9. Low SY, Taylor PM, Rennie MJ. Responses of glutamine transport in cultured rat skeletal muscle to osmotically induced changes in cell volume. J Physiol 1996; 492:877-885.
10. Hallbrucker C, Vom Dahl S, Lang F, Häussinger D. Control of hepatic proteolysis by amino acids. The role of cell volume. Eur J Biochem 1991; 197:717-724.
11. Jacobs DO, Kobayashi T, Imagire J, Grant C, Kesselly B, Wilmore DW. Sepsis after skeletal muscle energetics and membrane function. Surgery 1991; 110:318-326.
12. Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT. Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 1986; 164:1368-1373.
13. Le Boucher J, Obled C, Farges MC, Cynober L. Ornithine α-ketoglutarate modulates tissue protein metabolism in burn-injured rats. Am J Physiol (Endocrinol Metab) 1997; 270:E557-E563.
14. Wusteman M, Elia M. Effect of glutamine infusions on glutamine concentration and protein synthetic rate in rat muscle. J Parenter Enter Nutr 1991; 15:521-525.
15. Tamada H, Nezu R, Imamura I, Matsuo Y, Takagi Y, Kamata S, Okada A. The dipeptide alanyl-glutamine prevents intestinal mucosal atrophy in parenterally fed rats. J Parenter Enter Nutr 1992; 16:1106-1116.
16. Inoue Y, Grant JP, Snyder PJ. Effect of glutamine-supplemented total parenteral nutrition on recovery of the small intestine after starvation atrophy. J Parenter Enter Nutr 1993; 17:165-170.
17. Inoue Y, Grant JP, Snyder PJ. Effect of glutamine-supplemented intravenous nutrition on survival after Escherichia coli-induced peritonitis. J Parenter Enter Nutr 1993; 17:41-46.
18. Platell C, McCauley R, McCullough R, Hall J. Influence of glutamine and branched-chain amino acids on the jejunal atrophy associated with parenteral nutrition. J Gastroenterol Hepatol 1991; 3:345-349.
19. Fox AD, Kripke SA, DePaula J, Berman JM, Settle RG, Rombeau JL. Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. J Parenfer Enter Nutr 1988; 12:325-331.
20. Karatzas T, Scopa S, Tsoni I, Panagopoulos K, Spiliopoulou I, Moschos S, et al. Effect of glutamine on intestinal mucosal integrity and bacterial translocation after abdominal radiation. Clin Nutr 1991; 10:199-205.
21. Noguchi Y, James JH, Fischer JE, Hasselgren PO. Increased glutamine consumption in small intestine epithelial cells during sepsis in rats. Am J Surg 1996; 172:199-205.
22. Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, et al. L-Glutamine stimulates cell proliferation and activates mitogen-activated protein kinases. Am J Physiol (Gastrointest Liver Physiol) 1997; 272:G943-G953.
23. Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang B. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Physiol (Gastrointest Liver Physiol) 1997; 272:G879-G884.
24. Calder PC. Glutamine and the immune system. Clin Nutr 1994; 13:2-8.
25. Newsholme EA, Crabtree B, Ardawi MSM. The role of high rate of glycolysis and glutamine utilisation in rapidly dividing cells. Biosci Rep 1985; 5:393-400.
26. Yaqoob P, Calder PC. Glutamine requirement of proliferating T lymphocytes. Nutrition 1997; 13:646-651.
27. Furukawa S, Saito H, Fukatsu K, Kashiguchi Y, Inaba T, Lin MT, et al. Glutamine-enhanced bacterial killing by neutrophils from postoperative patients. Nutrition 1997; 13:863-869. The cytotoxicity of neutrophils from postoperative patients can be restored in vitro by incubation with physiological glutamine concentrations.
28. Cynober L. Glutamine as an activator of immune cells: how does it work? Nutrition 1997; 13:688-689.
29. Fahr MJ, Kornbluth J, Blossom S, Schaeffer R, Klimberg VS. Glutamine enhances immunoregulation of tumor growth. J Parenter Enter Nutr 1994; 14:471-476.
30. Li J, Kudsk KA, Janu P, Renegar KB. Effect of glutamine-enriched total parenteral nutrition on small intestinal gut-associated lymphoid tissue and upper respiratory tract immunity. Surgery 1997; 121:542-549.
31. Gennari R, Alexander W. Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis. Crit Care Med 1997; 25:1207-1214.
32. Blomqvist Bl, Hammarqvist F, Von der Decken A, Wernerman J. Glutamine and α-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement. Metabolism 1995; 44:1215-1222.
33. Wiren M, Adrian TE, Hammarqvist F, Johansson KE, Permert J, Petersson B, et al. The effect of a new amino-acid dipeptide solution on nitrogen balance and humoral growth factors in the postoperative state in man. Clin Nutr 1995; 14:97-104.
34. Petersson B, Waller SO, Von der Decken A, Vinnars E, Wernerman J. The long-term effect of postoperative TPN supplemented with glycylglutamine on protein synthesis in skeletal muscle [abstract]. Clin Nutr 1991; 10(suppl 2) :10.
35. Walser M. Misinterpretation of nitrogen balances when glutamine stores fall or are replenished. Am J Clin Nutr 1991; 53:1337-1338.
36. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 1992; 116:821-828.
37. Karner J, Roth E. Alanyl-glutamine infusions to patients with acute pancreatitis. Clin Nutr 1990; 9:43-44.
38. Palmer TEA, Griffiths RD, Jones C. Effect of parenteral L-glutamine on muscle in the very severely ill. Nutrition 1996; 12:316-320.
39. Long CL, Nelson KM, Di Renzo DB. Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients. J Parenter Enter Nutr 1995; 19:470-476.
40. O'Riordain MG, Fearon KG, Ross JA. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg 1994; 2:212-221.
41. Van der Hulst RRWJ, Von Meyenfeldt MF, Tiebosch A, Buurman WA, Soeters PB. Glutamine and intestinal immune cells in humans. J Parenfer Enter Nutr 1997; 21:310-315.
42. Tremel H, Kienle B, Weilemann LS, Stehle P, Fürst P. Glutamine dipeptide supplemented patenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994; 107:1595-1601.
43. Van der Hulst RRWJ, Van Kreel BK, Von Meyenfeldt MF, Brummer RJM, Arends JW, Deutz NEP, Soeters PB. Glutamine and the preservation of gut integrity. Lancet 1993; 341:1363-1365.
44. Hornsby-Lewis L, Shike M, Brown P, Klang M, Pearlstone D, Brennan MF. L-Glutamine supplementation in home total parenteral nutrition patients: stability, safety and effects on intestinal absorption. J Parenter Enter Nutr 1994; 12:268-273.
45. Wilmore DW, Lacey JM, Soultanakis RP, Bosch RL, Byrne TA. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997; 226:288-293. After 4 weeks treatment with GH, glutamine and a modified diet, half of a group of TPN-dependent adult patients were free of TPN support. At follow up, the percentage of patients who were not receiving TPN was 40%.
46. Scolapio JS, Camilleri M, Fleming R, Oenning LV, Burton DD, Sebo TJ, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113:1074-1081.
47. Griffiths RD, Jones C, Palmer TEA. Six-month outcome of critically ill patients given glutamine supplemented parenteral nutrition. Nutrition 1997; 13:295-302. This prospective, randomized, double-blind study evaluated the benefit of glutamine-supplemented versus isonitrogenous isoenergetic parenteral nutrition beyond the period of hospitalisation. It indicated a significant improvement in survival rate at 6 months together with a reduction in hospital costs per survivor.
48. Lacey JM, Crouch JP, Benfell K. The effects of glutamine-supplemented parenteral nutrition in premature infants. J Parenter Enter Nutr 1996; 2:74-80.
49. Roig JC, Bowling D, Dallas M, Sleasman J, Auestad N, Neu J. Enteral glutamine supplementation decreases nosocomial infection and alters T cell subset in very low birth weight infant [abstract]. Pediatr Res 1995; 37:285A.
50. Cynober L, Le Boucher J, Vasson MP. Arginine metabolism in mammals. J Nutr Biochem 1995; 6:402-413.
51. Houdijk APJ, Van Leeuwen PAM, Teerlink T, Flinkerbusch EL, Boermeester MA, Sauerwein HP, Wesdorp RIC. Glutamine-enriched enteral diet increases renal arginine production. J Parenter Enter Nutr 1994; 18:422-426.
52. Wakabayashi Y, Yamada E, Yoshida T, Takahashi N. Effect of intestinal resection and arginine-free diet on rat physiology. Am J Physiol (Gastrointest Liver Physiol) 1995; 269:G313-G318.
53. Seifter E, Rettura G, Barbul A, Levenson SM. Arginine: an essential amino acid for injured rats. Surgery 1978; 84:224-230.
54. Barbul A, Lazarou SA, Efron BA, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 1990; 108:331-337.
55. Shearer JD, Richards JR, Mills CD, Caldwell MD. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol (Endocrinol Metab) 1997; 272:E181-E190. From data on the arginine metabolism of resident mouse peritoneal exudate cells, the authors proposed a comprehensive model of the regulation of arginine metabolism during wound healing.
56. Albina JE, Mills CD, Henry WL, Caldwell MD. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 1990; 144:3877-3880.
57. Kirk SJ, Regan MC, Wasserkrug HL, Sodeyama M, Barbul A. Arginine enhances T-cell responses in athymic nude mice. J Parenter Enter Nutr 1992; 16:429-432.
58. Saito H, Trocki O, Wang SL, Gonce SJ, Joffe SN, Alexander JW. Metabolic and immune defects of dietary arginine supplementation after burns. Arch Surg 1987; 122:784-789.
59. Madden HP, Breslin RJ, Wasserkrug HL, Efron G, Barbul A. Stimulation of T-cell immunity by arginine enhances survival in peritonitis. J Surg Res 1988; 44:658-663.
60. Retura G, Barbul A, Levenson SM, Seifter E. Citrulline does not share the thymotropic properties of arginine and ornithine [Abstract]. Fed Proc 1979; 38:289.
61. Flynn NE, Wu G. Enhanced metabolism of arginine and glutamine in enterocytes of cortisol-treated pigs. Am J Physiol (Gastrointest Liver Physiol) 1997; 272:G474-G480.
62. Cynober L. Can arginine and ornithine support gut functions? Gut 1994; 35 (suppl 1) :S42-S45.
63. Raul F, Galluser M, Schleiffer R, Gosse F, Hasselmann M, Seiler N. Beneficial effects of L-arginine on intestinal epithelial restitution after ischemic damage in rats. Digestion 1995; 56:400-405.
64. Adjei AA, Yamauchi K, Nakasone Y, Konishi M, Yamamoto S. Arginine-supplemented diets inhibit endotoxin-induced bacterial translocation in mice. Nutrition 1995; 11:371-374.
65. Roth E. The impact of L-arginine-nitric oxide metabolism on ischemia/ reperfusion injury. Curr Opin Clin Nutr Metab Care 1998; 1:97-99.
66. Daly JM, Reynolds J, Thorn A, Kinsley L, Dietrick-Gallagher M, Shou J, Ruggieri B. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208:512-523.
67. Gottschlich MM, Jenkins M, Warden GD, Baumer T, Havens P, Snook JT. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. J Parenter Enter Nutr 1990; 14:225-236.
68. Mendez C, Jurkovich GJ, Garcia I, Davis D, Parker A, Maier RV. Effects of an immune-enhancing diet in critically injured patients. J Trauma 1997; 42:933-941. A prospective randomized controlled trial of early postoperative enteral feeding with an IED after severe trauma. The authors showed an earlier normalization of immune functions in the IED group without clear clinical benefit. The occurrence of acute respiratory distress syndrome before inclusion was, however, higher in the IED group.
69. Cerra FB, Lehmann S, Konstantinides N, Dzik J, Fish J, Konstantinides F, et al. Improvement in immune function in ICU patients by enteral nutrition supplemented with arginine, RNA, and menhaden oil is independent of nitrogen balance. Nutrition 1991; 7:193-199.
70. Bower RH, Cerra FB, Breshadsky B, Licari JJ, Hoyt D, Jensen G. Early enteral administration of a formula (Impact®) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449.
71. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, Rosato EF, Lavin P. Enteral nutrition with supplemented arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992; 112:56-67.
72. Schilling J, Vranjes N, Fierz W, Joller H, Gyurech D, Ludwig E, et al. Clinical outcome and immunology of postoperative arginine, to-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat IV solutions. Nutrition 1996; 12:423-429.
73. Senkal M, Mumme A, Eickhoff U, Geier B, Späth G, Wulfert D, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997; 25:1489-1496. A prospective randomized controlled trial of early enteral feeding with an IED compared with an isonitrogenous isocaloric diet after surgery for gastrointestinal cancer. Results indicated a decreased frequency of late (after day 5) infectious and wound complications in the IED group.
74. Gianotti L, Braga M, Vignali A, Balzano G, Zerbi A, Bisagni P, DiCarlo V. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997; 132:1222-1230.
75. Braga M, Gianotti L, Cestari A, Vignali A, Pellegatta F, Dolci A, DiCarlo V. Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. Arch Surg 1996; 131:1257-1265.
76. Heslin MJ, Latkany L, Leung D, Brooks AD, Hochwald SN, Pisters PWT, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997; 226:567-580. A prospective randomized controlled trial of early postoperative enteral feeding with an IED versus intravenous crystalloid solutions after resection of upper gastrointestinal malignancy. Analysis on an intention-to-treat basis failed to show any impact on complications and length of hospital stay.
77. Saffle JR, Wiebke G, Jennings K, Morris SE, Barton RG. Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma 1997; 42:793-802.
78. Moore FA, Moore EE, Kudsk AA, Brown RO, Bower RH, Koruda MJ. Clinical benefits of an immune-enhancing diet for early post-injury enteral feeding. J Trauma 1994; 37:607-615.
79. Kudsk KA, Minard G, Croce MA, Brown RO, Lowrey TS, Pritchard FE, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg 1996; 224:531-543. In this prospective randomized trial of IED enteral feeding versus an isonitrogenous formula in severely injured patients, infectious complications were lowest in the IED group.
80. Trémolières J, Scheggia E, Flament Cl. Effets de l'alpha-cétoglutarate d'ornithine sur le bilan azoté et sur la vitesse d'oxydation de l'éthanol. Cah Nutr Diet 1972; 7:2-7.
81. Cynober LA. Ornithine α-ketoglutarate. In: Amino acid metabolism and therapy in health and nutritional disease. Cynober LA (editor): Boca Raton: CRC Press; 1995; pp. 385-395.
82. Le Bricon T, Cynober L, Baracos VE. Ornithine α-ketoglutarate limits muscle protein breakdown without stimulating tumor growth in rats bearing Yoshida ascites hepatoma. Metabolism 1994; 43:899-905.
83. Le Bricon T, Cynober L, Field CJ, Baracos VE. Supplemental nutrition with ornithine α-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support. J Nutr 1995; 125:2999-3010.
84. Le Boucher J, Coudray-Lucas C, Lasnier E, Jardel A, Ekindjian OG, Cynober LA. Enteral administration of ornithine α-ketoglutarate or arginine α-ketoglutarate: a comparative study of their effects on glutamine pools in burn-injured rats. Crit Care Med 1997; 25:293-298.
85. Stoll B, Haussinger D. Functional hepatocyte heterogeneity. Eur J Biochem 1989; 181:709-716.
86. De Bandt JP, Cynober L, Lim SK, Coudray-Lucas C, Poupon R, Giboudeau J. Metabolism of ornithine, alpha-ketoglutarate and arginine in isolated perfused rat liver. Br J Nutr 1995; 73:227-239.
87. Roth E, Karner J, Roth Merten A, Winkler L, Valentini L, Schaupp K. Effect of α-ketoglutarate infusion on organ balances of glutamine and glutamate in anaesthetized dogs in catabolic state. Clin Sci 1991; 80:625-631.
88. Welbourne TC. Alpha-ketoglutarate, ornithine and growth hormone displace glutamine dependent ammoniagenesis and enhance renal base generation and function. Clin Nutr 1993; 12:49-50.
89. Roth Merten A, Karner J, Winkler S, Valentini L, Schaupp K, Roth E. Influence of α-ketoglutarate infusion on glutamate and glutamine metabolism. Clin Nutr 1990; 9:46-47.
90. Winkler S, Hölzenbein T, Karner J, Roth E. Kinetics of organ specific metabolism of a bolus injection into the jejunum of glutamine, α-ketoglutarate, ornithine, and ornithine α-ketoglutarate. Clin Nutr 1993; 12:56-57.
91. Castillo L, Sanchez M, Vogt J, Chapman TE, DeRojas-Walker TX, Tannenbaum SR, et al. Plasma arginine, citrulline, and ornithine kinetics in adults, with observations on nitric oxide synthesis. Am J Physiol (Endocrinol Metab) 1995; 268:E360-E367.
92. Raul F, Gossé F, Galluser M, Hasselmann M, Seiler N. Functional and metabolic changes in intestinal mucosa of rats after enteral administration of ornithine α-ketoglutarate salt. J Parenter Enter Nutr 1995; 19:145-150.
93. Czernichow B, Nsi-Emvo E, Galluser M, Gossé F, Raul F. Enteral supplementation with ornithine α-ketoglutarate improves the early adaptive response to resection. Gut 1997; 40:67-72.
94. De Oca J, Bettonica C, Cuadrado S, Vallet J, Martin E, Garcia A, et al. Effect of oral supplementation of ornithine-α-ketoglutarate on the intestinal barrier after orthotopic small bowel transplantation. Transplantation 1997; 63?:436-439.
95. Le Bricon T, Coudray-Lucas C, Lioret N, Lim SK, Plassart F, Schlegel L, et al. Ornithine α-ketoglutarate metabolism after enteral administration in burn patients: bolus compared with continuous infusion. Am J Clin Nutr 1997; 65:512-518. This prospective randomized controlled trial of the supplementation of enteral diet with ornithine α-ketoglutarate compared with an isonitrogenous control in burns patients indicates that bolus OKG administration promotes the synthesis of glutamine, arginine and proline thus explaining the beneficial clinical effects.
96. De Bandt JP, Coudray-Lucas C, Lioret N, Lim SK, Saizy R, Giboudeau J, Cynober L. A randomized controlled trial of the influence of the mode of enteral ornithine α-ketoglutarate administration in burn patients. J Nutr 1998 (in press).
97. Lasnier E, Coudray-Lucas C, Le Boucher J, Jardel A, Cynober L. Ornithine α-ketoglutarate counteracts thymus involution and glutamine depletion in endotoxemic rats. Clin Nutr 1996; 15:197-200.
98. Roch-Arveiller M, Tissot M, Coudray-Lucas C, Fontagne J, Giroud JP, Cynober L. Immunomodulatory effects of ornithine α-ketoglutarate in rats with burn injuries. Arch Surg 1996; 131:718-723.
99. Albina JE. Ornithine α-ketoglutarate enhances macrophage tumor cytotoxicity [Abstract]. Clin Nutr 1993; 12 (suppl) :51.
100. Duranton B, Schleiffer R, Gossé F, Raul F. Preventive administration of ornithine α-ketoglutarate improves intestinal mucosal repair after transient ischemia in rats. Crit Care Med 1998; 26:120-125.
101. Hammarqvist F, Wernerman J, Ali MR, Vinnars E. Effects of an amino acid solution enriched with either branched chain amino acids or ornithine α-ketoglutarate on the postoperative intracellular amino acid concentration of skeletal muscle. Br J Surg 1990; 77:214-218.
102. Jeevanandam M. Ornithine α-ketoglutarate in trauma. Clin Nutr 1993; 12:61-62.
103. Hammarqvist F, Wernerman J, von der Decken A, Vinnars E. Alpha-ketoglutarate preserves protein synthesis and free glutamine in skeletal muscle after surgery. Surgery 1991; 109:28-36.
104. Werneman J. Alpha ketoglutarate in the treatment of post-operative and critically ill patients. Clin Nutr 1993; 12:58-59.
105. Donati L, Signorini M, Grappolini S. Ornithine α-ketoglutarate administration in burn injury. Clin Nutr 1993; 12:70-71.
106. Le Bever H, Coudray-Lucas C, Carsin H, De Bandt JP, Cynober L. Action de l'α-cétoglutarate d'ornithine chez le brûlé: résultats d'une étude prospective, contrôlée, randomisée, en double aveugle, contre groupe isoazoté [Abstract]. Nutr Clin Métabol 1993; 7 (suppl) :33.
107. Leander U, Fürst P, Vesterberg K, Vinnars E. Nitrogen sparing effect of ornicetil in the immediate postoperative state: clinical chemistry and nitrogen balance. Clin Nutr 1985; 4:43-51.
108. Moukarzel AA, Goulet O, Salas JS, Mart-Henneberg C, Buchman AL, Cynober L, et al. Growth retardation in children receiving long-term total parenteral nutrition: effects of Ornithine α-ketoglutarate. Am J Clin Nutr 1994; 60:408-413.